First Heath Pharmaceuticals is thrilled to announce the participation at the European Society for Clinical Cell Analysis, ESCCA 2019, of one of its major collaboration groups, the academic research team of the University of Milan at Humanitas Clinical and Research Center of Rozzano (Milan).
ESCCA is a scientific society founded to promote and improve the use of clinical samples and flow cytometry application for clinical purpose. ESCCA 2019 will take place on 18-21 September 2019 in Bergen, Norway.
During the conference, our collaboration group will present the results of an one-year research project into the effects of one of our RNA Helicase Inhibitors on vasculogenesis and Kaposi Sarcoma.
First Health Pharmaceuticals is proud to have our very own Alessia Tarditi and Matteo Andreini as co-authors of the scientific poster that will be presented during the conference.
We thank Professor Silvia Della Bella and her group for this collaboration that led to important research findings regarding the anti angiogenic properties of one of our most important antitumor benchmark compounds.